Clinical Trials | Database Study of Cell Transplant in Medicare Myelofibrosis Subjects

The University of Virginia Cancer Center seeks adults for a database study, sponsored by the Center for International Blood and Marrow Transplant Research (CIBMTR), that collects information about patients who have myelofibrosis that is undergoing stem cell transplantation. The goal of this research is to determine if stem cell transplants are beneficial for patients with myelofibrosis. You may be able to participate in this study if you are a Medicare beneficiary member, have myelofibrosis, and if you are going to receive an allogeneic stem cell transplant in the USA. . In order to participate, at your pre-transplant visit, you will be asked to provide medical information including details about your cancer diagnosis and updates about your stem cell transplant. The medical information will be sent to CIBMTR to be combined with other participates information and analyzed. Your medical information will be protected and not be stored with anything that can directly identify you. The stem cell transplant will be no charge to you; it will be charged to Medicare. Additional information can be found here: NCT02934477 [email protected]